New High Yield Bond Ratings October 26 – October 30, 2020

At least 24 companies received downgrades or revisions on high yield bond ratings during the week of October 26 – October 30, 2020. These downgrades caused S&P Global Ratings to issue a negative or watch negative outlook to all of the companies. The Energy sector saw the majority of downgrades during this week.

Source: S&P

Here is a snapshot of some downgrades throughout the week:

October 27

Immunomedics Inc. bought Gilead Sciences Inc., a U.S. pharmaceutical maker, for $21 billion. Considering the cash and debt the acquisition, S&P believes the Gilead's leverage advances to roughly 2.5x.

The company's rating was downgraded to BBB+ and removed from CreditWatch, but not without negative implications.

The company also has elevated pressure to generate new reve...

Login In

or

Register now for free access

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments